View Older Stories View More Recent Stories
-
LendingClub (LC) Raises Expected IPO Price Range to $12-$14
-
BMO Capital Upgrades Arch Capital (ACGL) to Outperform
-
Apple (AAPL) Price Target Raised at BMO Capital; Sees Unfulfilled iPhone 6 Demand Pushed Into March Quarter
-
BMO Capital Upgrades Arch Capital (ACGL) to Outperform; Well Positioned to Outperform Peers
-
BMO Capital Downgrades Allied World Assurance (AWH) to Market Perform on Valuation
-
BMO Capital Downgrades PartnerRe (PRE) to Underperform; Sees Need for Primary Business
-
Array BioPharma (ARRY) MEK Deal 'Favorable', BMO Capital Says
-
Notable Analyst Rating Changes 12/4: (INFI) (MBLY) (CSX) Upgraded; (DISH) (RIO) (WMT) Downgraded
-
BMO Capital Downgrades Tupperware Brands (TUP) to Underperform
-
BMO Capital Downgrades Thor Industries Inc. (THO) to Market Perform
-
Kindred Setback on AtoKin 'Incrementally Positive' for Zoetis (ZTS) - BMO Capital
-
Kindred Biosciences (KIN) PT Cut to $14 at BMO Capital; Outperform Maintained
-
AppliedMicro to Present at Upcoming Investor Conferences in New York
-
BMO Capital Upgrades TreeHouse Foods (THS) to Outperform
-
BMO Capital Says Biogen's (BIIB) BIIB037 Impresses in Alzheimer
-
National Health Investors (NHI) Prices Larger 3.85M Common Offering at $63.80/Share
-
BMO Capital Starts 2U, Inc. (TWOU) at Outperform
-
Five Prime Therapeutics' (FPRX) Bristol-Myers Collaboration Validates Thesis, BMO Capital Says
-
BMO Capital Upgrades Berry Plastics Group (BERY) to Outperform
-
BMO Capital Downgrades Owens-Illinois (OI) to Market Perform
-
BMO Capital Downgrades The Macerich Company (MAC) to Market Perform
-
Streetinsider.com's Hot Lunchtime Reads 11/19: (FNMA) (CLF) (TSLA) (GLD)
-
BMO Capital Positive on Early Data for OncoMed's (OMED) OMP-52M51
-
Receptos (RCPT) Prices 3.6M Common Offering
-
Retail Opportunity Investments Corp. Prices Offering of Senior Unsecured Notes
-
STORE Capital (STOR) IPO Closes Up 5.4% in Debut
-
Five9 Announces Upcoming Conference Participation
-
BMO Capital Downgrades Wells Fargo (WFC) to Market Perform
-
BMO Capital Starts US Steel (X) at Market Perform
-
BMO Capital Starts Stillwater Mining (SWC) at Outperform
-
BMO Capital Starts Steel Dynamics (STLD) at Outperform
-
BMO Capital Starts Noranda Aluminum (NOR) at Outperform
-
BMO Capital Starts Freeport-McMoRan (FCX) at Market Perform
-
BMO Capital Starts Constellium (CSTM) at Market Perform
-
BMO Capital Starts CONSOL Energy (CNX) at Outperform
-
BMO Capital Starts Cloud Peak Energy (CLD) at Market Perform
-
BMO Capital Starts Century Aluminum (CENX) at Outperform
-
BMO Capital Starts Peabody Energy (BTU) at Market Perform
-
BMO Capital Starts Alpha Natural Resources (ANR) at Underperform
-
BMO Capital Starts AK Steel (AKS) at Market Perform
-
BMO Capital Starts Arch Coal Inc (ACI) at Underperform
-
BMO Capital Starts Alcoa (AA) at Market Perform
-
Zoetis (ZTS) Abbott Deal Seen as 'Good', BMO Capital Says; Focus Remains on Takeover Prospects (VRX)
-
Rocket Fuel to Present at Upcoming Investor Conferences
-
Receptos (RCPT) Reports Proposed Offering of Common Stock
-
Valeant Pharmaceuticals (VRX) Looking Past Allergan - BMO Capital
-
Apple (AAPL) Gains on Bullish Analyst Commentary
-
BMO Capital Downgrades Boise Cascade Company (BCC) to Market Perform
-
Notable Analyst Rating Changes 11/14: (RTN) (ESRT) (GERN) Upgraded; ((TJX) (LULU) (WMT) Downgraded
-
BMO Capital Downgrades Wal-Mart (WMT) to Underperform

